Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), July 8, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced the half-year report of the liquidity contract with Crédit Industriel et Commercial.
Genfit: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial
Seeking Alpha / 49 minutes from now 1 Views
Comments